Venkataraman Sriram 4
4 · Osmotica Pharmaceuticals plc · Filed Nov 23, 2020
Insider Transaction Report
Form 4
Venkataraman Sriram
Director10% Owner
Transactions
- Other
Ordinary Shares
2020-11-20−4,936,926→ 0 total(indirect: By Avista Capital investment fund)
Holdings
- 1,032,995(indirect: By Avista Capital investment fund)
Ordinary Shares
- 15,730,864(indirect: By Avista Capital investment fund)
Ordinary Shares
Footnotes (3)
- [F1]Represents shares of the Issuer held by Orbit Co-Invest I LLC. Effective November 20, 2020, Avista Capital Partners III GP, L.P. ("ACP GP") ceased to be the manager of Orbit Co-Invest I LLC. Mr. Venkataraman is a member of the investment committee of ACP GP. As a result, Mr. Venkataraman ceased to have voting or investment power with respect to the shares held by Orbit Co-Invest I LLC.
- [F2]Represents shares of the Issuer held by Avista Healthcare Partners, L.P. ("AHP"). Avista Healthcare Partners GP, Ltd. ("AHP GP") is the general partner of AHP. Mr. Venkataraman is a member of the investment committee of AHP GP. By virtue of this relationship, Mr. Venkataraman may be deemed to share voting and investment power with respect to the shares held by AHP. Mr. Venkataraman disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein, and the inclusion of the shares in this report shall not be deemed to be an admission of beneficial ownership of the reported shares for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise.
- [F3]Represents shares of the Issuer held by Orbit Co-Invest III LLC. ACP GP is the manager of Orbit Co-Invest III LLC. Mr. Venkataraman is a member of the investment committee of ACP GP. By virtue of this relationship, Mr. Venkataraman may be deemed to share voting and investment power with respect to the shares held by Orbit Co-Invest III LLC. Mr. Venkataraman disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein, and the inclusion of the shares in this report shall not be deemed to be an admission of beneficial ownership of the reported shares for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise.